Dubroff: Central Coast food producers must adapt
Agriculture on the Central Coast is in the midst of a rapid transformation. Regulation, drought and the soaring demand for locally produced food are forcing farmers across the region to adapt or shut their doors. The players who survive will likely be more sustainable and much more efficient. Curiously, they will likely reach markets that Read More →
Read More →Stellar Biotechnologies offerings raise $6.75 million
Stellar Biotechnologies, a Port Hueneme-based company which makes medicines from the blood of animals found only off the coast of California, closed two private offerings July 6. Stellar closed one offering of 1.7 million common shares sold to institutional investors for $4 per share. In a separate concurrent offering, the company also sold 1.3 million Read More →
Read More →Ceres faces lawsuit over sale to Land ‘O Lakes
Thousand Oaks-based ag-biotech company Ceres Inc. is facing a lawsuit from shareholders angry about the company’s June 17 sale to Minneapolis-based Land ‘O Lakes. In the lawsuit, which was filed in state court in Los Angeles on July 5, three shareholders allege the company unfairly sold the company to Land ‘O Lakes for $17.6 million. Read More →
Read More →Mark Melchiori pleads not guilty to 47 felonies
The former president of Melchiori Construction Co., Mark Melchiori, pleaded not guilty at a July 5 arraignment to 47 felonies including fraud and embezzlement. A preliminary hearing is set for Sept. 6. He was arrested in June on 47 felony charges, including prevailing wage fraud, embezzlement, diversion of construction funds, insurance fraud, violations of the Read More →
Read More →Europeans OK Amgen’s Kyprolis for multiple myeloma treatment
European regulators approved Amgen’s potential blockbuster drug Kyprolis on July 4 as a treatment for multiple myeloma. The European Commission approved a treatment of Kyprolis and dexamethasone in patients who’ve received at least one previous multiple myeloma treatment. In November, the commission approved a Kyprolis treatment using lenalidomide and dexamethasone for patients who’ve received at Read More →
Read More →LTC Properties announces monthly dividend of 18 cents per share
Westlake Village-based LTC Properties has declared a monthly cash dividend on its common stock for the third quarter of 2016. The dividend will be 18 cents per common share per month for July, August and September 2016, payable on July 29, Aug. 31 and Sept. 30, 2016, respectively, to stockholders of record on July 21, Read More →
Read More →Inphi sells memory product business for $90 million
Inphi sold its memory product business to Rambus for $90 million in cash June 30. The Santa Clara-based company, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a large engineering force in Thousand Oaks. The sale will allow it to focus on its communications business, Inphi said in Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
